prof.dr. (J.L.

Dean Erasmus School of Health Policy & Management
Erasmus University Rotterdam
+31 10 4088583

Latest academic publication

N. Büyükkaramikli, H.M. Blommestein, R. Riemsma, N. Armstrong, F.J. Clay, J. Ross, G. Worthy, J.L. Severens, J. Kleijnen & M.J. Al (2017). Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics (Print).

More information

Back to overview

Since 2009 Hans Severens is professor of Evaluation in Health Care at the iMTA. He holds a MSc Policy and Management in Health Sciences from the Maastricht University, and a PhD from the Radboud University Nijmegen, the Netherlands. From 2001 until 2009 he was appointed as professor of Medical Technology Assessment at Maastricht University and co-head of the department of Clinical Epidemiology and Medical Technology Assessment of the University Hospital Maastricht. Hans’ work is focused on economic evaluations of health care technologies, either as part of clinical trials or independent modelling studies and working on the research methods within this field. Since 2008 Hans is a full member of the Dutch National Health Council (GezondheidsRaad) and for over 7 years member of the Committee ‘Farmaceutische Hulp’ (CFH) of the Health Care Insurance Board (CVZ), for drug reimbursement advice). He is former member of the Board of Directors of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and was co-editor of the scientific journal of this society, ‘Value in Health’ for 10 years.


Visiting address

Burg. Oudlaan 50 3062 PA Rotterdam

Postal address

Postbus 1738 3000 DR Rotterdam